AU2013204740A1 - Methods of treating cancer using angiogenin or an angiogenin agonist - Google Patents
Methods of treating cancer using angiogenin or an angiogenin agonistInfo
- Publication number
- AU2013204740A1 AU2013204740A1 AU2013204740A AU2013204740A AU2013204740A1 AU 2013204740 A1 AU2013204740 A1 AU 2013204740A1 AU 2013204740 A AU2013204740 A AU 2013204740A AU 2013204740 A AU2013204740 A AU 2013204740A AU 2013204740 A1 AU2013204740 A1 AU 2013204740A1
- Authority
- AU
- Australia
- Prior art keywords
- angiogenin
- methods
- treating cancer
- agonist
- angiogenin agonist
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 102100022987 Angiogenin Human genes 0.000 title 2
- 108010072788 angiogenin Proteins 0.000 title 2
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000000556 agonist Substances 0.000 title 1
- 201000011510 cancer Diseases 0.000 title 1
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2013204740A AU2013204740C1 (en) | 2012-05-10 | 2013-04-12 | Methods of treating cancer using angiogenin or an angiogenin agonist |
PCT/AU2013/000478 WO2013166555A1 (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
NZ631749A NZ631749A (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
JP2015510577A JP2015517471A (en) | 2012-05-10 | 2013-05-10 | Cancer treatment method |
RU2014149807A RU2014149807A (en) | 2012-05-10 | 2013-05-10 | WAYS OF TREATMENT OF MALIGNANT NEW FORMATIONS USING ANGIOGENIN OR AN ANGIOGENIN AGONIST |
CN201380037180.4A CN104470533A (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
BR112014027967A BR112014027967A2 (en) | 2012-05-10 | 2013-05-10 | cancer treatment methods using angiogenin or an angiogenin agonist |
US14/399,852 US9839676B2 (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
EP13787726.2A EP2846820A4 (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
CA2872850A CA2872850A1 (en) | 2012-05-10 | 2013-05-10 | Methods of treating cancer using angiogenin or an angiogenin agonist |
JP2018023212A JP2018100288A (en) | 2012-05-10 | 2018-02-13 | Methods of treating cancer |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2012901918 | 2012-05-10 | ||
AU2012901918A AU2012901918A0 (en) | 2012-05-10 | Methods for treating cancer | |
AU2013204740A AU2013204740C1 (en) | 2012-05-10 | 2013-04-12 | Methods of treating cancer using angiogenin or an angiogenin agonist |
Publications (3)
Publication Number | Publication Date |
---|---|
AU2013204740A1 true AU2013204740A1 (en) | 2013-12-12 |
AU2013204740B2 AU2013204740B2 (en) | 2015-04-23 |
AU2013204740C1 AU2013204740C1 (en) | 2015-10-01 |
Family
ID=49549993
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2013204740A Ceased AU2013204740C1 (en) | 2012-05-10 | 2013-04-12 | Methods of treating cancer using angiogenin or an angiogenin agonist |
Country Status (10)
Country | Link |
---|---|
US (1) | US9839676B2 (en) |
EP (1) | EP2846820A4 (en) |
JP (2) | JP2015517471A (en) |
CN (1) | CN104470533A (en) |
AU (1) | AU2013204740C1 (en) |
BR (1) | BR112014027967A2 (en) |
CA (1) | CA2872850A1 (en) |
NZ (1) | NZ631749A (en) |
RU (1) | RU2014149807A (en) |
WO (1) | WO2013166555A1 (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009137880A1 (en) | 2008-05-14 | 2009-11-19 | Agriculture Victoria Services Pty Ltd | Use of angiogenin or angiogenin agonists for treating diseases and disorders |
AU2013204740C1 (en) | 2012-05-10 | 2015-10-01 | Agriculture Victoria Services Pty Ltd | Methods of treating cancer using angiogenin or an angiogenin agonist |
KR20160127076A (en) * | 2014-03-06 | 2016-11-02 | 유니버시티 오브 써던 캘리포니아 | Use of short term starvation regimen in combination with kinase inhibitors to enhance traditional chemo-drug efficacy and feasibility and reverse side effects of kinases in normal cells and tissues |
Family Cites Families (48)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2623509B1 (en) | 1987-11-19 | 1990-04-20 | Centre Nat Rech Scient | 17 KD PROTEIN WITH ANGIOGENIC ACTION, METHOD FOR ISOLATING IT FROM MAMMALIAN MILK, THERAPEUTIC COMPOSITIONS CONTAINING SAME, METHOD FOR DETECTION AND / OR DOSAGE AND IMMUNOLOGICAL REAGENTS FOR DETECTION AND DOSAGE OF ANGIOGENINS OF MAMMALS, AND OF THEIR FRAGMENTS |
EP0620709B1 (en) | 1992-01-15 | 1995-10-18 | Campina Melkunie B.V. | Process for isolating lactoferrin and lactoperoxidase from milk and milk products |
JP3880063B2 (en) | 1993-03-18 | 2007-02-14 | シティミューン サイエンシーズ,インコーポレイテッド | Compositions and methods for reducing the toxicity of biologically active agents |
JP3112637B2 (en) | 1994-09-30 | 2000-11-27 | 雪印乳業株式会社 | Bone strengthener |
JP2974604B2 (en) | 1996-01-23 | 1999-11-10 | 雪印乳業株式会社 | Basic protein composition, basic peptide composition and use thereof |
JP3929088B2 (en) | 1996-06-20 | 2007-06-13 | 雪印乳業株式会社 | Bone formation promoter and bone resorption inhibitor |
RU2110066C1 (en) | 1996-12-27 | 1998-04-27 | Московский государственный университет прикладной биотехнологии | Method of quantitatively determining angiogenin in biological sample |
NL1005677C2 (en) | 1997-03-27 | 1998-09-29 | Campina Melkunie Bv | Method for recovering growth factors, or a composition containing one or more growth factors, from milk or a derivative thereof. |
KR100236977B1 (en) * | 1997-11-01 | 2000-01-15 | 윤재승 | A fusion protein of hegf and human antiogenin, and process for preparing the same |
CA2331620A1 (en) | 1998-05-11 | 1999-11-18 | The Endowment For Research In Human Biology, Inc. | Use of neomycin for treating angiogenesis-related diseases |
AU782394B2 (en) | 1999-06-29 | 2005-07-21 | J. Alexander Marchosky | Compositions and methods for forming and strengthening bone |
EP1217070A1 (en) | 2000-12-22 | 2002-06-26 | CellGenix Technologie Transfer GmbH | Selective cytotoxic fusion proteins |
TW200526779A (en) | 2001-02-08 | 2005-08-16 | Wyeth Corp | Modified and stabilized GDF propeptides and uses thereof |
RU2204262C2 (en) | 2001-07-06 | 2003-05-20 | Московский государственный университет прикладной биотехнологии | Method for preparing biologically active protein concentrate enriched with pancreatic ribonuclease a, angiogenin and lysozyme from dairy ultrafiltrate |
CN1161467C (en) * | 2001-07-09 | 2004-08-11 | 中国人民解放军军事医学科学院生物工程研究所 | Fusion protein with anti-tumor effect and application of the protein |
JP4291967B2 (en) | 2001-11-08 | 2009-07-08 | 雪印乳業株式会社 | Skin collagen production promoter |
EP1529054A4 (en) | 2001-11-27 | 2005-12-28 | Univ Washington | THERAPEUTIC PROTEIN AND TREATMENTS |
PL383616A1 (en) | 2002-12-20 | 2008-04-14 | Amgen Inc. | Agents binding and inhibiting miostatin |
JP4698935B2 (en) | 2003-05-07 | 2011-06-08 | 雪印乳業株式会社 | Skin collagen production promoter |
WO2004106491A2 (en) | 2003-05-22 | 2004-12-09 | The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services | Angiogenin-based hiv-1 therapies |
US8114969B2 (en) * | 2003-10-01 | 2012-02-14 | Isis Innovation, Ltd. | Immunotoxin derived from a recombinant human autoantibody and method of using thereof |
EP1678123A1 (en) | 2003-10-15 | 2006-07-12 | Bayer HealthCare AG | Tetrahydro-naphthalene and urea derivatives |
US20050180957A1 (en) | 2004-01-16 | 2005-08-18 | Scharp David W. | Method of using fibrin-bound angiogenic factors to stimulate vascularization of transplant site of encapsulated cells |
US8147561B2 (en) | 2004-02-26 | 2012-04-03 | Endosphere, Inc. | Methods and devices to curb appetite and/or reduce food intake |
EP3006039B1 (en) | 2004-03-02 | 2021-01-06 | Acceleron Pharma Inc. | Alk7 polypeptides for use in promoting fat loss |
EP1765365A4 (en) * | 2004-06-22 | 2008-02-20 | Pro Pharmaceuticals Inc | Compositions and methods ofr the co-delivery of anti-cancer drugs, anti-angiogenic drugs, and a polysaccharide |
GB0425625D0 (en) | 2004-11-22 | 2004-12-22 | Royal College Of Surgeons Ie | Treatment of disease |
US20060251739A1 (en) | 2005-05-04 | 2006-11-09 | National Yang-Ming University | Composition and method for treating autoimmune disease and mucosal disorder |
US20090036369A1 (en) | 2005-07-26 | 2009-02-05 | Kirin Pharma Kabushiki Kaisha | Anti-tumor agents comprising r-spondins |
WO2007023479A2 (en) | 2005-08-23 | 2007-03-01 | Royal College Of Surgeons In Ireland | Treatment of central nervous system injury |
US7612041B2 (en) | 2005-11-23 | 2009-11-03 | Acceleron Pharma Inc. | Isolated activin-binding ActRIIa polypeptide comprising the SEQ ID NO: 7 and uses for promoting bone growth |
CA2633131A1 (en) | 2005-12-21 | 2007-06-28 | Viventia Biotech Inc. | Novel cancer-associated antigen |
AR060632A1 (en) | 2006-04-26 | 2008-07-02 | Genentech Inc | PHOSFOINOSITIDE INHIBITING COMPOUNDS 3- KINASE AND METHODS OF USE |
US8021659B2 (en) | 2006-04-28 | 2011-09-20 | Naidu Lp | Coenzyme Q10, lactoferrin and angiogenin compositions and uses thereof |
US20070275036A1 (en) | 2006-05-18 | 2007-11-29 | Celldyne Biopharma, Llc | Avian follistatin product |
JP2009543868A (en) * | 2006-07-17 | 2009-12-10 | クインテセンス バイオサイエンシーズ インコーポレーティッド | Methods and compositions for cancer treatment |
CN101626693B (en) | 2006-11-10 | 2014-05-14 | 墨累古尔本合作有限公司 | Process for preparation of angiogenin |
US7601689B2 (en) | 2007-04-12 | 2009-10-13 | Naidu Lp | Angiogenin complexes (ANGex) and uses thereof |
JP5384502B2 (en) * | 2007-09-11 | 2014-01-08 | モンドバイオテック ラボラトリーズ アクチエンゲゼルシャフト | Use of somatostatin-14 as a therapeutic agent |
RU2010150934A (en) * | 2008-05-14 | 2012-06-20 | Эгрикалчер Виктория Сервисиз Пти Лтд (Au) | ORAL DRUG |
WO2009137880A1 (en) | 2008-05-14 | 2009-11-19 | Agriculture Victoria Services Pty Ltd | Use of angiogenin or angiogenin agonists for treating diseases and disorders |
WO2009137881A1 (en) | 2008-05-14 | 2009-11-19 | Agriculture Victoria Services Pty Ltd | Angiogenin-enriched milk fractions |
AU2013204721B2 (en) | 2008-05-14 | 2016-08-18 | Agriculture Victoria Services Pty Ltd | Methods for treating cachexia |
US20120328591A1 (en) * | 2009-11-18 | 2012-12-27 | Agriculture Victoria Services Pty Ltd | Methods for improving oral delivery |
WO2011060489A1 (en) | 2009-11-18 | 2011-05-26 | Murray Goulburn Co-Operative Co. Limited | Transgenic non-human animals |
US20130243728A9 (en) | 2009-11-18 | 2013-09-19 | Agriculture Victoria Services Pty Ltd | Recombinant microorganisms |
WO2013051767A1 (en) | 2011-10-06 | 2013-04-11 | 중앙대학교 산학협력단 | Novel use of angiogenin |
AU2013204740C1 (en) | 2012-05-10 | 2015-10-01 | Agriculture Victoria Services Pty Ltd | Methods of treating cancer using angiogenin or an angiogenin agonist |
-
2013
- 2013-04-12 AU AU2013204740A patent/AU2013204740C1/en not_active Ceased
- 2013-05-10 WO PCT/AU2013/000478 patent/WO2013166555A1/en active Application Filing
- 2013-05-10 JP JP2015510577A patent/JP2015517471A/en active Pending
- 2013-05-10 CN CN201380037180.4A patent/CN104470533A/en active Pending
- 2013-05-10 NZ NZ631749A patent/NZ631749A/en not_active IP Right Cessation
- 2013-05-10 CA CA2872850A patent/CA2872850A1/en not_active Abandoned
- 2013-05-10 RU RU2014149807A patent/RU2014149807A/en unknown
- 2013-05-10 US US14/399,852 patent/US9839676B2/en not_active Expired - Fee Related
- 2013-05-10 BR BR112014027967A patent/BR112014027967A2/en not_active IP Right Cessation
- 2013-05-10 EP EP13787726.2A patent/EP2846820A4/en not_active Withdrawn
-
2018
- 2018-02-13 JP JP2018023212A patent/JP2018100288A/en active Pending
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL288181A (en) | Methods of treating cancer | |
EP3071209A4 (en) | Use of sting agonist as cancer treatment | |
EP3060207A4 (en) | Methods and compositions for treating cancer | |
IL237791A0 (en) | Method of treating cancer | |
EP3027192A4 (en) | Methods for the treatment of solid tumors | |
EP2964028A4 (en) | Compounds for treatment of cancer | |
EP3057594A4 (en) | Method of treating cancer | |
EP2968254A4 (en) | Methods of treating lung cancer | |
EP3077049A4 (en) | Compositions and methods for treating vitiligo | |
EP2895206A4 (en) | Method of treating cancer | |
EP2988659A4 (en) | Improved methods of cancer detection | |
EP2970419B8 (en) | Methods of treating colorectal cancer | |
EP2965086A4 (en) | Methods of detecting prostate cancer | |
EP3008212A4 (en) | Methods of treatment of cancer | |
SG11201508878WA (en) | Methods of treating cancer | |
EP3004395A4 (en) | Compositions and methods for treating cancer | |
EP3052102A4 (en) | Compositions and methods for treating cancers | |
EP3074040A4 (en) | Method of treating cancer | |
EP3057593A4 (en) | Treatment for pancreatic cancer | |
EP3011013A4 (en) | Methods for treatment of ovarian cancer | |
EP3082841A4 (en) | Methods for treating an animal | |
ZA201507762B (en) | Methods of treating cancer | |
EP2991650A4 (en) | Methods for the treatment of cancer | |
AU2013204740A1 (en) | Methods of treating cancer using angiogenin or an angiogenin agonist | |
EP2846820A4 (en) | Methods of treating cancer using angiogenin or an angiogenin agonist |